These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23891970)

  • 1. Invasion as target for therapy of glioblastoma multiforme.
    Vehlow A; Cordes N
    Biochim Biophys Acta; 2013 Dec; 1836(2):236-44. PubMed ID: 23891970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotropic Chemotherapy to Abrogate Glioblastoma Multiforme Migration/Invasion.
    Helson L; Majeed M
    Anticancer Res; 2019 Jul; 39(7):3423-3427. PubMed ID: 31262865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Trials: Unraveling Motility Phenotypes, Progression Patterns, and Treatment Options for Glioblastoma Multiforme.
    Raman F; Scribner E; Saut O; Wenger C; Colin T; Fathallah-Shaykh HM
    PLoS One; 2016; 11(1):e0146617. PubMed ID: 26756205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.
    Simpson L; Galanis E
    Expert Rev Anticancer Ther; 2006 Nov; 6(11):1593-607. PubMed ID: 17134364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Investigational Perspective for Purines Against Glioblastoma Invasiveness.
    Giuliani P; Zuccarini M; Carluccio M; Ziberi S; Di Iorio P; Caciagli F; Ciccarelli R
    Curr Drug Targets; 2018; 19(16):1871-1881. PubMed ID: 29484991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Experimenter's Guide to Glioblastoma Invasion Pathways.
    de Gooijer MC; Guillén Navarro M; Bernards R; Wurdinger T; van Tellingen O
    Trends Mol Med; 2018 Sep; 24(9):763-780. PubMed ID: 30072121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib.
    Areeb Z; Stylli SS; Ware TM; Harris NC; Shukla L; Shayan R; Paradiso L; Li B; Morokoff AP; Kaye AH; Luwor RB
    Med Oncol; 2016 May; 33(5):53. PubMed ID: 27098175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression.
    Chou YC; Chang MY; Wang MJ; Yu FS; Liu HC; Harnod T; Hung CH; Lee HT; Chung JG
    Oncol Rep; 2015 Nov; 34(5):2489-96. PubMed ID: 26352173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The sodium pump could constitute a new target to combat glioblastomas].
    Lefranc F; Mijatovic T; Kiss R
    Bull Cancer; 2008 Mar; 95(3):271-81. PubMed ID: 18390407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin inhibitor cilengitide for the treatment of glioblastoma: a brief overview of current clinical results.
    Scaringi C; Minniti G; Caporello P; Enrici RM
    Anticancer Res; 2012 Oct; 32(10):4213-23. PubMed ID: 23060541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
    Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
    Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.
    Lucio-Eterovic AK; Piao Y; de Groot JF
    Clin Cancer Res; 2009 Jul; 15(14):4589-99. PubMed ID: 19567589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma.
    She X; Yu Z; Cui Y; Lei Q; Wang Z; Xu G; Xiang J; Wu M; Li G
    Oncol Rep; 2014 Sep; 32(3):957-64. PubMed ID: 25017996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy.
    Kundu P; Mohanty C; Sahoo SK
    Acta Biomater; 2012 Jul; 8(7):2670-87. PubMed ID: 22484149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oct-3/4 promotes migration and invasion of glioblastoma cells.
    Kobayashi K; Takahashi H; Inoue A; Harada H; Toshimori S; Kobayashi Y; Goto K; Sugimoto K; Yano H; Ohnishi T; Tanaka J
    J Cell Biochem; 2012 Feb; 113(2):508-17. PubMed ID: 21938739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents.
    Minniti G; Muni R; Lanzetta G; Marchetti P; Enrici RM
    Anticancer Res; 2009 Dec; 29(12):5171-84. PubMed ID: 20044633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-molecule agonists of mammalian Diaphanous-related (mDia) formins reveal an effective glioblastoma anti-invasion strategy.
    Arden JD; Lavik KI; Rubinic KA; Chiaia N; Khuder SA; Howard MJ; Nestor-Kalinoski AL; Alberts AS; Eisenmann KM
    Mol Biol Cell; 2015 Nov; 26(21):3704-18. PubMed ID: 26354425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme.
    Yan W; Zhang W; Sun L; Liu Y; You G; Wang Y; Kang C; You Y; Jiang T
    Brain Res; 2011 Sep; 1411():108-15. PubMed ID: 21831363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel cellular and post-genomic technologies in the treatment of glioblastoma multiforme (Review).
    Bryukhovetskiy I; Bryukhovetskiy A; Khotimchenko Y; Mischenko P
    Oncol Rep; 2016 Feb; 35(2):639-48. PubMed ID: 26548844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.